1/22/2013

Dilon Diagnostics is reporting positive results for molecular breast imaging from two studies. The first study showed MBI has a higher sensitivity in finding cancers compared with mammography and ultrasound. In the second study, MBI performed comparably with MRI in identifying cancers.

Related Summaries